18204338

Source:http://linkedlifedata.com/resource/pubmed/id/18204338

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001792, umls-concept:C0030705, umls-concept:C0036043, umls-concept:C0245561, umls-concept:C0332173, umls-concept:C1269683
pubmed:issue	1
pubmed:dateCreated	2008-1-21
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00062673
pubmed:abstractText	To compare the safety and tolerability profile of duloxetine versus placebo in elderly (> or = 65 years) patients with major depressive disorder (MDD).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8109496
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes, http://linkedlifedata.com/resource/pubmed/chemical/duloxetine
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0271-0749
pubmed:author	pubmed-author:DesaiahDurisalaD, pubmed-author:DinkelJames JJJ, pubmed-author:KatonaCorneliusC, pubmed-author:RaskinJoelJ, pubmed-author:WalkerDaniel JDJ, pubmed-author:WiltseCurtis GCG
pubmed:issnType	Print
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	32-8
pubmed:meshHeading	pubmed-meshheading:18204338-Aged, pubmed-meshheading:18204338-Aged, 80 and over, pubmed-meshheading:18204338-Antidepressive Agents, pubmed-meshheading:18204338-Depressive Disorder, Major, pubmed-meshheading:18204338-Dose-Response Relationship, Drug, pubmed-meshheading:18204338-Double-Blind Method, pubmed-meshheading:18204338-Drug Administration Schedule, pubmed-meshheading:18204338-Female, pubmed-meshheading:18204338-Humans, pubmed-meshheading:18204338-Male, pubmed-meshheading:18204338-Thiophenes
pubmed:year	2008
pubmed:articleTitle	Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
pubmed:affiliation	Lilly Research Laboratories, Eli Lilly Canada, Toronto, Ontario, Canada. joel.raskin@lilly.com
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study